Tranexamic Acid Neurotoxicity After Nebulization and BAL
CHEST · 2024
DOI: 10.1016/j.chest.2024.05.021 ↗Kurz gefasst
Fallbericht in der Zeitschrift CHEST, 2024. Verfasst von Jeremy Hardin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Toxicology, Department of Emergency Medicine, UC San Diego Health, CA; VA San Diego Healthcare System, San Diego, CA; San Diego D…. Hauptthemen laut MEDLINE: Tranexamic Acid, Bronchoscopy, Antifibrinolytic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Tranexamic acid is a commonly used hemostatic agent with broad clinical uses across multiple specialties. Systemic toxicity is due to gamma-aminobutyric acid type A and glycine receptor competitive antagonism and has been reported by multiple routes, but toxicity after pulmonary administration via nebulization and BAL has not yet been described. A 44-year-old man with a history of congenital pulmonary arteriovenous malformations underwent routine bronchoscopy for hemoptysis. He received preprocedure nebulized tranexamic acid 500 mg three times daily for 48 h. An additional 1,000 mg was given via BAL for intraprocedural hemostasis. One hour after the procedure, he developed altered mental status, myoclonus, and hyperthermia, which was ultimately controlled with propofol and vecuronium. As the use of pulmonary tranexamic acid increases, toxicity from this agent should be considered. Dose reductions and alternate treatment modalities should be considered in patients with advanced age, arteriovenous malformations, and renal insufficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Medical Toxicology, Department of Emergency Medicine, UC San Diego Health, CA; VA San Diego Healthcare System, San Diego, CA; San Diego Division, California Poison Control System, San Diego, CA. Electronic a…
- Division of Medical Toxicology, Department of Emergency Medicine, UC San Diego Health, CA.
- Division of Medical Toxicology, Department of Emergency Medicine, UC San Diego Health, CA; VA San Diego Healthcare System, San Diego, CA; San Diego Division, California Poison Control System, San Diego, CA.
- Division of Medical Toxicology, Department of Emergency Medicine, UC San Diego Health, CA; San Diego Division, California Poison Control System, San Diego, CA.
- Department of Pathology, UC San Diego Health, San Diego, CA; Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego Health, San Diego, CA.
Zitieren
APA
Hardin, J., Seltzer, J., Moriguchi, R., Yeung, K., Galust, H., Corbett, B., Schneir, A., Clark, R. F., & Suhandynata, R. T. (2024). Tranexamic Acid Neurotoxicity After Nebulization and BAL. CHEST. https://doi.org/10.1016/j.chest.2024.05.021
Vancouver
Hardin J, Seltzer J, Moriguchi R, Yeung K, Galust H, Corbett B, et al. Tranexamic Acid Neurotoxicity After Nebulization and BAL. CHEST. 2024. doi:10.1016/j.chest.2024.05.021
BibTeX
@article{Hardin2024,
author = {Hardin, Jeremy and Seltzer, Justin and Moriguchi, Riku and Yeung, Kara and Galust, Henrik and Corbett, Bryan and Schneir, Aaron and Clark, Richard F and Suhandynata, Raymond T},
title = {Tranexamic Acid Neurotoxicity After Nebulization and BAL},
journal = {CHEST},
year = {2024},
doi = {10.1016/j.chest.2024.05.021}
}
EUVIMED